KLP Kapitalforvaltning’s iRadimed IRMD Stock Holding History
Bought
Maintained
Sold
Other funds holding IRMD
KLP Kapitalforvaltning's IRMD Position: Q3 2026 in Review
KLP Kapitalforvaltning increased its iRadimed (IRMD) stake by 176% in Q3 2026, buying an estimated $916K and bringing the position to 16,000 shares worth $1.38M. The position accounts for ﹤0.01% of the portfolio, ranked #927.
KLP Kapitalforvaltning first reported a position in IRMD in Q4 2024 and has held it in 8 quarters since. 212 funds tracked by Wall St. Rank hold IRMD as of Q3 2026.
- KLP Kapitalforvaltning held 16,000 shares of iRadimed worth $1.38M as of Q3 2026.
- KLP Kapitalforvaltning bought 10,200 iRadimed shares in Q3 2026, an estimated $916K.
- iRadimed made up ﹤0.01% of KLP Kapitalforvaltning's portfolio in Q3 2026, its #927 holding.
- KLP Kapitalforvaltning first reported a position in iRadimed in Q4 2024 and has held it in 8 quarters since.
- 212 funds tracked by Wall St. Rank held iRadimed as of Q3 2026.
Based on KLP Kapitalforvaltning's 13F filing for Q3 2026, filed 10 Nov 2026.